panitumumab,cetuximab
merck,takeda,amgen,eli lilly
['party', 'cetuximab', 'panitumumab']
it s like an egfr party. #asco22 i think is the year where we pretty much should say egfr (cetuximab/panitumumab) should be chosen over vegf . sequencing matters similar os trends like yesterday. summary: don t reserve the best for last. 
Oncologist | Researcher | ColorectalCancer #CRCSM???????@MayoClinic @PittTweet Alum; ??#ctDNA #LiquidBiopsies??#PrecisionOncology ViewsMy Own. COI @ASCO #ASCO22